Millendo Therapeutics Sets Bar High For Venture Capital, Life Sciences Investment In Michigan
ANN ARBOR - In what is said to be the largest venture capital round in Michigan history, Millendo Therapeutics, formerly known as Atterocor Inc., announced this week it raised $62 million that will be used, in part, to pay new partner AstraZeneca for the rights to market a new cancer-fighting drug. The pharmaceutical giant also








